Correlation Between Genovate Biotechnology and Kenmec Mechanical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genovate Biotechnology and Kenmec Mechanical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovate Biotechnology and Kenmec Mechanical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genovate Biotechnology Co and Kenmec Mechanical Engineering, you can compare the effects of market volatilities on Genovate Biotechnology and Kenmec Mechanical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovate Biotechnology with a short position of Kenmec Mechanical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovate Biotechnology and Kenmec Mechanical.

Diversification Opportunities for Genovate Biotechnology and Kenmec Mechanical

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Genovate and Kenmec is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Genovate Biotechnology Co and Kenmec Mechanical Engineering in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kenmec Mechanical and Genovate Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovate Biotechnology Co are associated (or correlated) with Kenmec Mechanical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kenmec Mechanical has no effect on the direction of Genovate Biotechnology i.e., Genovate Biotechnology and Kenmec Mechanical go up and down completely randomly.

Pair Corralation between Genovate Biotechnology and Kenmec Mechanical

Assuming the 90 days trading horizon Genovate Biotechnology is expected to generate 4.56 times less return on investment than Kenmec Mechanical. In addition to that, Genovate Biotechnology is 1.54 times more volatile than Kenmec Mechanical Engineering. It trades about 0.01 of its total potential returns per unit of risk. Kenmec Mechanical Engineering is currently generating about 0.09 per unit of volatility. If you would invest  2,578  in Kenmec Mechanical Engineering on September 1, 2024 and sell it today you would earn a total of  5,942  from holding Kenmec Mechanical Engineering or generate 230.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.79%
ValuesDaily Returns

Genovate Biotechnology Co  vs.  Kenmec Mechanical Engineering

 Performance 
       Timeline  
Genovate Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genovate Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Genovate Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Kenmec Mechanical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kenmec Mechanical Engineering has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Genovate Biotechnology and Kenmec Mechanical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genovate Biotechnology and Kenmec Mechanical

The main advantage of trading using opposite Genovate Biotechnology and Kenmec Mechanical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovate Biotechnology position performs unexpectedly, Kenmec Mechanical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kenmec Mechanical will offset losses from the drop in Kenmec Mechanical's long position.
The idea behind Genovate Biotechnology Co and Kenmec Mechanical Engineering pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance